(FHR3) has also been reported to bind C3Bb leading to inhibition of C3Bb C3 convertase activity (Fritsche et al. 2010 ). CFH also acts as a cofactor for the factor I-mediated proteolytic inactivation of C3b to iC3b. Pangburn, MK., Schreiber, RD., Muller-Eberhard, HJ. (1977) . Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J Exp Med, 146, Weiler, JM., Daha, MR., Austen, KF., Fearon, DT. (1976) 
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